Spyre Therapeutics, Inc. (SYRE)

Insiders sold $43.3M in the past 12 months, 97% under disclosed plans; their starting stakes can't be measured from the filings. Why

Latest filing: Filed Oct 2 for a sale on Oct 1. Heidy King-Jones sold 29K shares ($2.6M) under a disclosed plan. Filing